Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.8%

3 terminated out of 44 trials

Success Rate

88.9%

+2.3% vs benchmark

Late-Stage Pipeline

20%

9 trials in Phase 3/4

Results Transparency

33%

8 of 24 completed with results

Key Signals

8 with results89% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (18)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (6)

Trial Status

Completed24
Unknown10
Recruiting4
Terminated3
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

88.9%

Benchmark: 86.6%

Based on 24 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT07173179Phase 4CompletedPrimary

Papillary Epinephrine Injection vs Rectal Indomethacin

NCT07661498Phase 4Not Yet Recruiting

Indomethacin for Biliary ERCP Patients

NCT06260878Phase 4RecruitingPrimary

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

NCT05664074Phase 4CompletedPrimary

Rectal Indomethacin vs Intravenous Ketorolac

NCT07391787CompletedPrimary

Low-acid Contrast Media for Preventing Post ERCP Pancreatitis

NCT05252754Phase 3RecruitingPrimary

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

NCT07117318Not ApplicableRecruitingPrimary

Rectal NSAIDs With/Without PD Stent for PEP Prevention

NCT05336630Not ApplicableCompletedPrimary

Study of Forceps Cannulation During ERCP

NCT05267379RecruitingPrimary

An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis

NCT06727851Enrolling By InvitationPrimary

ESGE-Quality Improvement in Endoscopy: ERCP

NCT04691674Not ApplicableCompleted

Optimal Placement Duration of Pancreatic Duct Stent

NCT05947461Not ApplicableTerminatedPrimary

Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac

NCT06367322CompletedPrimary

Statins and Post-ERCP Acute Pancreatitis (Stark Project)

NCT05800626UnknownPrimary

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

NCT04546867Not ApplicableCompletedPrimary

Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis Before Endoscopic Removal

NCT05310409CompletedPrimary

PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms

NCT05857514Not ApplicableUnknownPrimary

Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis

NCT03098082Not ApplicableCompletedPrimary

Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis

NCT02602574UnknownPrimary

ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?

NCT04770857UnknownPrimary

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis

Scroll to load more

Research Network

Activity Timeline